- Home
- SCOR vs MRNS Comparison
SCOR vs MRNS Comparison
Compare SCOR & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- MRNS
- Stock Information
- Founded
- SCOR 1999
- MRNS 2003
- Country
- SCOR United States
- MRNS United States
- Employees
- SCOR N/A
- MRNS N/A
- Industry
- SCOR Business Services
- MRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- MRNS Health Care
- Exchange
- SCOR Nasdaq
- MRNS Nasdaq
- Market Cap
- SCOR 34.7M
- MRNS 29.9M
- IPO Year
- SCOR 2007
- MRNS 2014
- Fundamental
- Price
- SCOR $7.13
- MRNS N/A
- Analyst Decision
- SCOR Buy
- MRNS Buy
- Analyst Count
- SCOR 3
- MRNS 12
- Target Price
- SCOR $12.83
- MRNS $4.28
- AVG Volume (30 Days)
- SCOR 34.7K
- MRNS 1.2M
- Earning Date
- SCOR 03-05-2025
- MRNS 03-04-2025
- Dividend Yield
- SCOR N/A
- MRNS N/A
- EPS Growth
- SCOR N/A
- MRNS N/A
- EPS
- SCOR N/A
- MRNS N/A
- Revenue
- SCOR $356,212,000.00
- MRNS $31,466,000.00
- Revenue This Year
- SCOR N/A
- MRNS $14.97
- Revenue Next Year
- SCOR $2.92
- MRNS $57.65
- P/E Ratio
- SCOR N/A
- MRNS N/A
- Revenue Growth
- SCOR N/A
- MRNS 1.63
- 52 Week Low
- SCOR $4.89
- MRNS $0.22
- 52 Week High
- SCOR $20.42
- MRNS $10.50
- Technical
- Relative Strength Index (RSI)
- SCOR 49.61
- MRNS 8.78
- Support Level
- SCOR $6.84
- MRNS $0.54
- Resistance Level
- SCOR $8.06
- MRNS $0.55
- Average True Range (ATR)
- SCOR 0.52
- MRNS 0.00
- MACD
- SCOR -0.06
- MRNS -0.07
- Stochastic Oscillator
- SCOR 16.08
- MRNS 0.00
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. The platforms measure include televisions, mobile devices, computers, tablets, CTV devices and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada and Others. It provides solutions for Automotive, Digital Media, Financial Services, FMCG, Pharmaceutical , Retail, Technology and Travel.
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.